Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial.
Saved in:
| Title: | Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial. |
|---|---|
| Authors: | Touchefeu Y; Gastrointestinal Oncology Unit, Institut des Maladies de l'Appareil Digestif, University Hospital, 1 place Alexis Ricordeau, 44093, Nantes Cedex 1, France. yann.touchefeu@chu-nantes.fr., Guimbaud R; Digestive Medical Oncology IUCT Rangueil, CHU de Toulouse, Toulouse, France., Louvet C; Oncology Multidisciplinary Research Group (GERCOR), 151 rue du Faubourg Saint Antoine, 75011, Paris, France., Dahan L; Digestive Oncology Unit, AP-HM, La Timone Hospital, Aix-Marseille Université, Marseille, France., Samalin E; Digestive Oncology Department, Institut du Cancer de Montpellier, Montpellier, France., Barbier E; Fédération Francophone de Cancérologie Digestive-EPICAD INSERM LNC-UMR 1231, University of Burgundy and Franche Comté, Dijon, France., Le Malicot K; Fédération Francophone de Cancérologie Digestive-EPICAD INSERM LNC-UMR 1231, University of Burgundy and Franche Comté, Dijon, France., Cohen R; Department of Oncology, Sorbonne Université, AP-HP, hôpital Saint-Antoine, 75012, Paris, France., Gornet JM; Department of Gastroenterology, AP-HP Hôpital Saint Louis, Paris, France., Aparicio T; Department of Gastroenterology and Digestive Oncology, Saint Louis Hospital, APHP, University Denis Diderot, Sorbonne Paris Cité, Paris, France., Nguyen S; Oncology Multidisciplinary Research Group (GERCOR), 151 rue du Faubourg Saint Antoine, 75011, Paris, France., Azzedine A; Department of oncology, CH Montélimar, Montélimar, France., Etienne PL; Oncology Department, CARIO, HPCA, Plérin, France., Phelip JM; Service HGE et Oncologie Digestive, CHU de Saint Etienne, Unité HESPER EA-7425 Université Jean Monnet/Claude Bernard Lyon 1, Villeurbanne, France., Hammel P; Digestive Oncology Unit, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris, Clichy, France., Chapelle N; Gastrointestinal Oncology Unit, Institut des Maladies de l'Appareil Digestif, University Hospital, 1 place Alexis Ricordeau, 44093, Nantes Cedex 1, France., Sefrioui D; Digestive Oncology Unit, Department of Hepato-Gastroenterology, Rouen University Hospital, UNIROUEN, Inserm U1245, IRON group, Normandie University, 76000, Rouen, France., Mineur L; Institut Sainte Catherine, Avignon, France., Lepage C; Gastroenterology Department, INSERM UMR1231, CHU de Dijon, University Bourgogne Franche-Comté, Dijon, France., Bouche O; Digestive Oncology, CHU REIMS, Reims, France. |
| Source: | Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2019 May; Vol. 22 (3), pp. 577-586. Date of Electronic Publication: 2018 Oct 11. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 100886238 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1436-3305 (Electronic) Linking ISSN: 14363291 NLM ISO Abbreviation: Gastric Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1436-3305 |
|---|---|
| DOI: | 10.1007/s10120-018-0885-z |
